Giovanni Di Minno
#165,243
Most Influential Person Now
Researcher
Giovanni Di Minno's AcademicInfluence.com Rankings
Giovanni Di Minnocomputer-science Degrees
Computer Science
#9851
World Rank
#10334
Historical Rank
Artificial Intelligence
#4776
World Rank
#4839
Historical Rank
Database
#6801
World Rank
#7040
Historical Rank
Download Badge
Computer Science
Giovanni Di Minno's Degrees
- PhD Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Giovanni Di Minno Influential?
(Suggest an Edit or Addition)Giovanni Di Minno's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. (1999) (326)
- Factor V Leiden Is Associated with Repeated and Recurrent Unexplained Fetal Losses (1997) (266)
- Increased Risk for Venous Thrombosis in Carriers of the Prothrombin GA20210 Gene Variant (1998) (254)
- Genetic Modulation of Oral Anticoagulation with Warfarin (2000) (253)
- Factor V Leiden, C>T MTHFR Polymorphism and Genetic Susceptibility to Preeclampsia (1997) (240)
- Measuring plasma fibrinogen to predict stroke and myocardial infarction. (1990) (218)
- Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. (1985) (204)
- Insight into the nature of the CRP-coronary event association using Mendelian randomization. (2006) (191)
- Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. (1985) (181)
- Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe (2002) (175)
- Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. (1998) (168)
- Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. (2004) (165)
- Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke (2002) (164)
- Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism. (1993) (163)
- Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) (2013) (160)
- PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. (1998) (159)
- The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin (1998) (158)
- Homocysteine, coagulation, platelet function, and thrombosis. (2000) (157)
- Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritis (2013) (143)
- Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study (2012) (139)
- Oxidative Stress and Platelet Activation in Homozygous Homocystinuria (2001) (138)
- Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. (1999) (137)
- The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. (1998) (132)
- International recommendations on the diagnosis and treatment of acquired hemophilia A (2020) (132)
- Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. (1996) (131)
- Coexistence of Factor V Leiden and Factor II A20210 Mutations and Recurrent Venous Thromboembolism (1999) (130)
- Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. (1983) (130)
- Familial thrombophilia and the occurrence of fetal growth restriction. (2001) (120)
- The risk of venous thromboembolism in patients with cirrhosis (2016) (118)
- Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. (1994) (115)
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATION (1981) (113)
- Red Wine Consumption and Cardiovascular Health (2019) (112)
- Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors (2009) (104)
- Monitoring the entry of new platelets into the circulation after ingestion of aspirin. (1983) (103)
- Carotid Intima-Media Thickness in Psoriatic Arthritis: Differences Between Tumor Necrosis Factor-&agr; Blockers and Traditional Disease-Modifying Antirheumatic Drugs (2011) (101)
- Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study. (1998) (98)
- Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. (2000) (97)
- The first ambulatory screening on thromboembolism: a multicentre, cross‐sectional, observational study on risk factors for venous thromboembolism (2005) (94)
- An Alternative Method for PAI-1 Promoter Polymorphism (4G/5G) Typing (1997) (93)
- Preventing adverse obstetric outcomes in women with genetic thrombophilia. (2002) (92)
- Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study. (2017) (90)
- Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies (2012) (89)
- Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. (1997) (87)
- Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. (1996) (86)
- Prothrombotic Genetic Risk Factors and the Occurrence of Gestational Hypertension with or without Proteinuria (1999) (84)
- New Insights Into the Treatment of Glanzmann Thrombasthenia. (2016) (84)
- Cost of care of haemophilia with inhibitors (2010) (82)
- Homocysteine and arterial thrombosis: Challenge and opportunity (2010) (82)
- Monitoring the Entry of New Platelets Into the Circulation After Ingestion of Aspirin (1983) (80)
- Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy. (2006) (78)
- Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER) (2013) (77)
- Perioperative handling of patients on antiplatelet therapy with need for surgery (2009) (77)
- Plasma Folate, Vitamin B12, and Total Homocysteine and Homozygosity for the C677T Mutation of the 5,10-Methylene Tetrahydrofolate Reductase Gene in Patients with Alzheimer’s Dementia (2001) (76)
- Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. (2009) (74)
- Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies. (2015) (73)
- Effects of an Epoxymethano Stable Analogue of Prostaglandin Endoperoxides (U-46619) on Human Platelets (1981) (73)
- Desmopressin in inherited disorders of platelet function (2007) (72)
- Association of Plasminogen Activator Inhibitor (PAI)-1 (SERPINE1) SNPs With Myocardial Infarction, Plasma PAI-1, and Metabolic Parameters: The HIFMECH Study (2007) (70)
- Prostaglandins as Inhibitors of Human Platelet Aggregation (1979) (70)
- High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria (1997) (68)
- Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies (2010) (68)
- Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta‐analysis (2016) (67)
- EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. (2005) (66)
- The plasminogen activator inhibitor‐1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study (2003) (65)
- Glanzmann’s Thrombasthenia: Identification of 19 New Mutations in 30 Patients (2002) (62)
- Gender differences in left ventricular chamber and midwall systolic function in normotensive and hypertensive adults (2003) (59)
- Magnetic resonance imaging and ultrasound evaluation of “healthy” joints in young subjects with severe haemophilia A (2013) (59)
- Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. (2016) (58)
- Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. (2008) (57)
- C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives. (2000) (57)
- Contribution of the Cystathionine β-Synthase Gene (844ins68) Polymorphism to the Risk of Early-onset Venous and Arterial Occlusive Disease and of Fasting Hyperhomocysteinemia (2000) (57)
- Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. (2015) (57)
- High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. (2010) (56)
- Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia (2013) (56)
- Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. (1986) (56)
- Haemophilia A: molecular insights (2007) (55)
- The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention (2015) (55)
- Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe (2004) (52)
- Cardiovascular Risk in Rheumatic Patients: The Link between Inflammation and Atherothrombosis (2012) (51)
- Predictors of Early Minimal Disease Activity in Patients with Psoriatic Arthritis Treated with Tumor Necrosis Factor-α Blockers (2012) (51)
- Replacement therapy for bleeding episodes in factor VII deficiency (2012) (50)
- Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. (2001) (49)
- Fibrinogen Plasma Levels in an Apparently Healthy General Population – Relation to Environmental and Genetic Determinants (1998) (48)
- The Infectious Burden in Atherothrombosis (2012) (48)
- Homozygous C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke. (1998) (47)
- Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. (2011) (46)
- Effects of angiotensin II on plasma ADH, prostaglandin synthesis, and water excretion in normal humans. (1985) (46)
- Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). (2014) (46)
- Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non‐alcoholic steatohepatitis (2007) (46)
- Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. (1999) (46)
- Raised Plasma Fibrinogen Concentrations in Subjects Attending a Metabolic Ward - Relation to Family History and Vascular Risk Factors (1995) (45)
- IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. (2015) (45)
- Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations. (2002) (45)
- Oral Anticoagulant Drugs and the Risk of Osteoporosis: New Anticoagulants Better than Old? (2015) (45)
- Functionally abnormal monocytes in hypercholesterolemia. (1993) (44)
- Italian intersociety consensus on DOAC use in internal medicine (2017) (44)
- Glanzmann’s thrombasthenia (defective platelet integrin αIIb-β3): proposals for management between evidence and open issues (2009) (44)
- Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. (2006) (43)
- Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells (2017) (43)
- Arthropathy in Patients with Moderate Hemophilia A: A Systematic Review of the Literature (2013) (43)
- Retinal Vein Occlusion and Inherited Conditions Predisposing to Thrombophilia (1998) (43)
- FV HR2 Haplotype as Additional Inherited Risk Factor for Deep Vein Thrombosis in Individuals with a High-Risk Profile (2002) (43)
- Endovascular Thrombolysis in Acute Mesenteric Vein Thrombosis: a 3-year follow-up with the rate of short and long-term sequaelae in 32 patients. (2010) (42)
- The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia (2015) (41)
- Diabetes, vascular complications and antiplatelet therapy: open problems (2009) (41)
- Determining sulfur‐containing amino acids by capillary electrophoresis: A fast novel method for total homocyst(e)ine human plasma (1999) (41)
- The effect of the interleukin-6 c/g-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels. (2001) (41)
- Hepatic Steatosis and Disease Activity in Subjects with Psoriatic Arthritis Receiving Tumor Necrosis Factor-α Blockers (2012) (41)
- Platelet Dysfunction in Uremia. Multifaceted Defect Partially Corrected by Dialysis (1986) (41)
- Endothelin abnormalities in patients with pulmonary embolism. (1997) (41)
- Increased troponin I predicts in-hospital occurrence of hemodynamic instability in patients with sub-massive or non-massive pulmonary embolism independent to clinical, echocardiographic and laboratory information. (2008) (40)
- Challenges in the prevention of venous thromboembolism in the elderly (2004) (40)
- Association Between the Metabolic Syndrome, Its Individual Components, and Unprovoked Venous Thromboembolism: Results of a Patient-Level Meta-Analysis (2014) (40)
- Factor XIII Val34Leu Polymorphism and Risk of Deep Vein Thrombosis (2000) (40)
- Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. (2011) (37)
- A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing. (2000) (36)
- Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins (2018) (36)
- Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders☆ (2015) (36)
- Overcoming limitations of current antiplatelet drugs: A concerted effort for more profitable strategies of intervention (2011) (36)
- Renal handling of urea in subjects with persistent azotemia and normal renal function. (1987) (35)
- Clinical Relevance of Polymorphic Markers of Arterial Thrombosis (1997) (35)
- Platelet Reactivity and Disease Activity in Subjects with Psoriatic Arthritis (2012) (34)
- Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update (2012) (34)
- Increased prostacyclin-like activity in vascular tissues from rats on long-term treatment with an oestrogen-progestagen combination. (1979) (33)
- Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair. (1983) (32)
- Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective (2010) (30)
- Clinical use of factor VIII and factor IX concentrates. (2013) (30)
- Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies (2017) (29)
- A prospective study on survival in cancer patients with and without venous thromboembolism (2013) (29)
- Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update. (2012) (29)
- Persistent Impairment of Platelet Aggregation following Cessation of a Short-course Dietary Supplementation of Moderate Amounts of N-3 Fatty Acid Ethyl Esters (1999) (28)
- Compound Heterozygosity (554-589 del, C515-T Transition) in the Platelet Glycoprotein Ibα Gene in a Patient with a Severe Bleeding Tendency (1999) (27)
- Association of a sequence variant in DAB2IP with coronary heart disease (2011) (27)
- Long‐lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3‐year pharmacological management (2002) (27)
- Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings. (2001) (26)
- Plasma and Platelet Lipid Composition and Platelet Aggregation by Arachidonic Acid in Women on the Pill (1981) (26)
- Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis. (2014) (26)
- The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A. (2016) (26)
- Efficacy and safety of prophylaxis with once-weekly BAY 79–4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients (2012) (26)
- Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives. (2015) (26)
- Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study). (2003) (25)
- Fibrinogen Naples I (Bβ A68T) nonsubstrate thrombin-binding capacities (2001) (25)
- Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice (2013) (25)
- Longer‐acting factor VIII to overcome limitations in haemophilia management: the PEGylated liposomes formulation issue (2010) (25)
- Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: A prospective multicenter cohort study (2012) (24)
- Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects (2005) (24)
- Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. (2005) (24)
- Methylene Tetrahydrofolate Reductase (MTHFR) 677T→C Mutation and Unexplained Early Pregnancy Loss (1998) (23)
- ACE, PAI‐1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with Type 1 diabetes (1999) (23)
- The role of ADP secretion and thromboxane synthesis in factor VIII binding to platelets. (1983) (23)
- Detection of the Factor V Leiden Using SSCP (1996) (23)
- In vitro inhibition by defibrotide of monocyte superoxide anion generation: a possible mechanism for the antithrombotic effect of a polydeoxyribonucleotide-derived drug. (1991) (23)
- Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis. (1990) (22)
- Acquired Haemophilia A in the Elderly: Case Reports (2010) (22)
- Genetic Polymorphism of 5,10-MTHFR Reductase Gene in Offspring of Patients with Myocardial Infarction (1999) (22)
- Denaturing HPLC procedure for factor IX gene scanning. (2003) (22)
- The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. (2002) (22)
- Left ventricular chamber and myocardial systolic function reserve in patients with type 1 diabetes mellitus: insight from traditional and Doppler tissue imaging echocardiography. (2006) (22)
- Mesoglycan: Clinical Evidences for Use in Vascular Diseases (2010) (22)
- Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis (2017) (21)
- Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? (2016) (21)
- Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine. (2019) (21)
- Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy (2013) (21)
- Hypercholesterolemia and platelets. (1993) (21)
- Angiotensin II inhibition with captopril on plasma ADH, PG synthesis, and renal function in humans. (1986) (21)
- Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research. (2015) (21)
- Haemophilia B: From Molecular Diagnosis to Gene Therapy (2003) (21)
- Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy (2008) (20)
- TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis (2012) (19)
- Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis (2021) (19)
- G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis. (2001) (19)
- Genetic modulation of plasma fibrinogen concentrations: Possible importance of interleukin-6 (2004) (19)
- Reduced in vivo oxidative stress following 5‐methyltetrahydrofolate supplementation in patients with early‐onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype (2005) (18)
- DIPYRIDAMOLE AND PLATELET FUNCTION (1978) (18)
- Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy (2012) (18)
- A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen). (1991) (18)
- Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs (2011) (18)
- Aspirin resistance and diabetic angiopathy: back to the future. (2004) (18)
- Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study (2019) (17)
- Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of β-fibrinogen genotype and environmental factors (2004) (17)
- Recombinant factor VIIa in a patient with Glanzmann’s thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment (2004) (17)
- Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies (2019) (17)
- Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients? (2017) (17)
- Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI) (2016) (17)
- Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury? (1998) (17)
- Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study (2016) (17)
- Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study. (2018) (16)
- Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients (2016) (16)
- Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series (2021) (16)
- Aspirin resistance and platelet turnover: a 25-year old issue. (2011) (16)
- A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors? (2011) (16)
- Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young". (2007) (16)
- Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome. (2007) (16)
- Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link. (1994) (16)
- Coronary artery disease, cerebral non-fatal ischemic stroke in retinal vein occlusion: an 8-yr follow-up. (2012) (16)
- Management of patients with long‐term inhibitors: is immune tolerance an underestimated life‐long solution? (2013) (15)
- Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy: correlations with PAI-1 and t-PA plasma levels. (2010) (15)
- Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia (2017) (15)
- Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients (2017) (15)
- Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C (and Congenital Bleeding Disorders): Where Do We Stand? (2013) (14)
- Polyunsaturated fatty acids, thrombosis and vascular disease (2002) (14)
- Homocysteine, platelet function and thrombosis. (1999) (14)
- New predictive approaches for ITI treatment (2014) (14)
- Risk of Myocardial Infarction in Carriers of Mutations in the Hemochromatosis-associated Gene (2000) (14)
- Filling the gap between science & clinical practice: prevention of stroke recurrence. (2012) (14)
- The use of antithrombotic drugs in older people. (2002) (14)
- Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient? (2015) (14)
- HELLP syndrome and its relation with the antiphospholipid syndrome. (2014) (14)
- Cardiovascular secondary prevention: patients' knowledge of cardiovascular risk factors and their attitude to reduce the risk burden, and the practice of family doctors. The "Help Your Heart Stay Young" study. (2004) (14)
- Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project (2019) (14)
- From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation. (2019) (14)
- Acute coronary syndrome and severe haemophilia: An unusual association with challenging treatment (2010) (14)
- Summary report of the First International Conference on inhibitors in haemophilia A. (2017) (13)
- Determination of atherogenesis in apolipoprotein E-knockout mice. (2000) (13)
- Drugs affecting plasma fibrinogen levels (1992) (13)
- Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. (2011) (13)
- Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow‐up study (2017) (13)
- A Frameshift Mutation in the Human Fibrinogen Aα-chain Gene (Aα [499] Ala Frameshift Stop) Leading to Dysfibrinogen San Giovanni Rotondo (2001) (13)
- Alcohol dosing and the heart: updating clinical evidence. (2011) (13)
- Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease (2014) (13)
- ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism (2017) (13)
- Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis. (2014) (13)
- The causal role of salt depletion in acute renal failure due to captopril in hypertensive patients with a single functioning kidney and renal artery stenosis. (1987) (12)
- Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status. (2019) (12)
- Management of bleeding disorders in adults (2012) (12)
- Influence of cardiovascular risk factors on relation between angiotensin converting enzyme‐gene polymorphism and blood pressure in arterial hypertension (1998) (12)
- OP0162 Obesity and the prediction of the minimal disease activity. A prospective study in psoriatic arthritis patients (2013) (12)
- Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention. (2010) (12)
- Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect (2014) (12)
- Comparative analysis of the pivotal studies of extended half‐life recombinant FVIII products for treatment of haemophilia A (2021) (12)
- INGESTION OF DIPYRIDAMOLE REDUCES INHIBITORY EFFECT OF PROSTACYCLIN ON HUMAN PLATELETS (1979) (12)
- Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities. (2001) (12)
- Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths. (2002) (12)
- Improving the use of direct oral anticoagulants in atrial fibrillation. (2013) (12)
- Can Serum TGF-BETA 1 Be Used to Evaluate the Response to Antiviral Therapy of Haemophilic Patients with HCV-Related Chronic Hepatitis ? (2008) (11)
- Long‐term prophylaxis with intermediate‐purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding (2006) (11)
- Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine (2017) (11)
- Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer (2018) (11)
- Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study. (2019) (11)
- Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG). (2001) (10)
- Presence of FV Leiden and MTHFR Mutation in a Patient with Complicated Pregnancies (1997) (10)
- Pathogen Safety of Long-Term Treatments for Bleeding Disorders: (Un)Predictable Risks and Evolving Threats (2013) (10)
- Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus (2006) (10)
- Laboratory tests during direct oral anticoagulant treatment? No (2013) (10)
- A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. (1998) (10)
- Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy. (2009) (10)
- Aspirin resistance and platelet turnover: a 25-year old issue. (2011) (10)
- A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo. (2001) (10)
- A new method for determination of plasma homocystine by isotope dilution and electrospray tandem mass spectrometry. (2006) (10)
- Prenatal diagnosis of haemophilia: our experience of 44 cases (2013) (9)
- Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A (2019) (9)
- Treatment Regimens with Bypassing Agents in Patients with Hemophilia A and Inhibitors: A Survey from the Italian Association of Hemophilia Centers (AICE) (2018) (9)
- Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders. (2015) (9)
- Work Productivity and Activity Impairment Questionnaire ( WPAI ) + Classroom Impairment Questions ( CIQ ) : Hemophilia Specific ( HS ) : (2019) (9)
- Cu/Zn superoxide dismutase in patients with non-familial Alzheimer’s disease (1995) (9)
- Pain assessment and management in Italian Haemophilia Centres. (2020) (9)
- The real effectiveness of ultrasound guidance in subclavian venous access. (2010) (9)
- A novel G-to-A mutation in the intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency. (2003) (9)
- The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes (2019) (9)
- Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies (2015) (8)
- Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients (2017) (8)
- Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
- OP0163 Weight loss and induction of minimal disease activity in psoriatic arthritis patients starting TNF-α blockers treatment (2013) (8)
- Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism. (2008) (8)
- Current and evolving features in the clinical management of haemophilia. (2014) (8)
- U-46619, a stable analogue of prostaglandin H2, induces retraction of human platelet-rich plasma clots. (1980) (8)
- Venous thromboembolism in the 3rd millennium: challenges to the management of venous thromboembolism in the elderly (2003) (8)
- The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies. (2020) (8)
- A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study. (2014) (8)
- Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry (2017) (8)
- Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation. (1984) (7)
- Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases. (2015) (7)
- Aspirin After Oral Anticoagulants for Prevention of Recurrence in Patients with Unprovoked Venous Thromboembolism. the Warfasa STUDY (2011) (7)
- Urinary excretion of iPF(2α)-III predicts the risk of future thrombotic events. A 10-year follow-up. (2012) (7)
- Searching for the thrombogenic mechanism(s) of fibrinogen. (1990) (7)
- Drugs affecting plasma fibrinogen levels. Implications for new antithrombotic strategies. (1996) (7)
- Lipids in platelet function: platelet and vascular prostaglandins in thromboembolic disease. (1987) (7)
- Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis (2020) (7)
- Individuals' cardiovascular risk profile projected by family doctors and individuals' knowledge of cardiovascular risk factors: a challenge for primary prevention. The cardiovascular risk prevention project "Help Your Heart Stay Young". (2005) (7)
- Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke (1995) (7)
- New anti-thrombotic drugs for stroke prevention. (2011) (7)
- The use of frozen-thawed platelet-derived phospholipids as a confirmatory test for the diagnosis of lupus anticoagulants. Comparison with two commercial confirmatory system tests. (1999) (7)
- Deep venous thrombosis in elderly hospitalized patients: prevalence and clinical features (2005) (7)
- The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. (2011) (6)
- Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (mthfr) gene in offspring of patients with myocardial infarction. (1999) (6)
- Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from Southern Italy (1999) (6)
- Biosimilars of low‐molecular‐weight heparin products: fostering competition or reducing ‘biodiversity’? (2016) (6)
- Methylation Reactions, the Redox Balance and Atherothrombosis: The Search for a Link with Hydrogen Sulfide (2015) (6)
- Acquired Hemophilia A Successfully Treated with Rituximab (2015) (6)
- The role of the metabolic syndrome in patients with provoked venous thromboembolic events (2013) (6)
- Platelet and monocyte variables in homocystinuria due to cystathionine-beta-synthase deficiency. (1997) (6)
- At Disease Presentation, Severity of the Bleeding Symptom Predicts the Following Bleeds in Patients with FVII Deficiency (2011) (5)
- Fibrinogen and mechanisms of thrombosis. A difficult link (1992) (5)
- A retrovirus carrying the polyomavirus middle T gene induces acute thrombocythemic myeloproliferative disease in mice (1988) (5)
- Plasmatic and vascular factors of the hemostatic system in rats receiving an estrogen-progestogen combination. (1980) (5)
- The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature (2017) (5)
- Hypercoagulability and atherothrombosis: clinical suggestions and perspectives. (2001) (5)
- Mechanisms of fibrinolysis and clinical use of thrombolytic agents. (1992) (5)
- Idiopathic Budd-Chiari syndrome in a patient with homozygous Factor V Leiden and heterozygous Factor II G20210A mutations. (2000) (5)
- Anticoagulant Therapy in Oncologic Patients Undergoing Venous Stenting for Superior Vena Cava Syndrome and Other Interventional Procedures (2014) (5)
- Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis (2019) (5)
- Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study (2020) (5)
- Increased PGI2 activity in venous tissues from rats on oral contraceptives is not prevented by heparin administration before vessel isolation. (1980) (4)
- Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project. (2021) (4)
- Plasma predictors of ischemic complications of atherosclerosis: open issues. (1993) (4)
- Common variants in the thrombomodulin gene as a risk for myocardial infarction in the north of Europe (HIFMECH Study) (2004) (4)
- The increased demand for plasma-derived factor VIII in Italy between 2011 and 2014 is attributable to treatment of adult patients rather than paediatric or previously unexposed patients with severe haemophilia A. (2017) (4)
- Efficacy and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) Prophylaxis in Patients with Severe Hemophilia a and Comorbidities: A Post Hoc Analysis of PROTECT VIII Data (2019) (4)
- Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors (2021) (4)
- Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates. (2013) (4)
- Newer agents for coronary thrombolysis. Perspectives from clinical studies. (1989) (4)
- Identifying human platelet glycoproteins IIb and IIIa by capillary electrophoresis (1998) (4)
- Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement. (2021) (4)
- Glanzmann’s thrombasthenia: strategies for identification and management (2017) (4)
- Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19) (2021) (4)
- Changes in insulin levels following 6-month treatment with recombinant human growth hormone in growth hormone-deficient adults. (2009) (4)
- Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides. (1982) (4)
- Adverse outcome in women with thrombophilia and bilateral uterine artery notches. (2006) (4)
- Effectiveness of endovascular thrombolysis in acute mesenteric vein thrombosis (2011) (4)
- Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis (2011) (4)
- Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications (2022) (3)
- Platelet fibrinogen binding in familial hypercholesterolemia. (1987) (3)
- The β-fibrinogen -455 G>A gene polymorphism is associated with peripheral vascular injury in systemic sclerosis patients. (2010) (3)
- Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER (2010) (3)
- Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis. (2001) (3)
- Vascular Complications of Homocystinuria: Incidence, Clinical Pattern and Treatment (2000) (3)
- Increased retraction of fibrin clots by endothelial cells of infants of diabetic mothers. (1985) (3)
- Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021. (2021) (3)
- Cytomegalovirus-Associated Splanchnic Vein Thrombosis in Immunocompetent Patients: Two Case Reports and Literature Review (2018) (3)
- RASopathies and hemostatic abnormalities: key role of platelet dysfunction (2021) (3)
- Isolated episodes of atrial fibrillation and acupuncture. (2003) (2)
- Predicting early and delayed bleedings in children who undergo adeno‐tonsillectomy surgery. Is it really possible? (2014) (2)
- Nonsubstrate thrombin-binding capacities (2001) (2)
- Effects of PGE2 infusion on renal function in normal man before and after angiotensin II inhibition by captopril. (1987) (2)
- In vivo platelet activation in homozygous cystathionine beta-synthase deficiency: a probucol-sensitive phenomenon. (1992) (2)
- Human genome, environment and medical practice (2013) (2)
- Blood stains of the Turin Shroud 2015: beyond personal hopes and limitations of techniques (2016) (2)
- Platelet aggregation: methodology and physiopathology. (1978) (2)
- Preclinical and prognostically relevant cardiovascular disease burden in systemic lupus erythematosus with low clinical damage index. (2008) (2)
- The antithrombotic potential of the vessel wall. Evidence from studies on patients prone to venous thrombosis. (1988) (2)
- The binding of fibrinogen to platelets in diabetes mellitus. (1986) (2)
- Reply to Rebuttal: Gene Variants of the Cytochrome P450 CYP2C9 Affect Oral Anticoagulation with Warfarin (2001) (2)
- Laboratory tests during direct oral anticoagulant treatment? Authors’ reply (2015) (2)
- Cost-effectiveness analysis of caplacizumab in the new standard of care for immune Thrombotic Thrombocytopenic Purpura in Italy (2021) (2)
- A novel G-toA mutation in intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency (2003) (2)
- Human Platelet Aggregation Induced by the Synthetic Endoperoxide Analogue U-46619 is Independent From Secretion, Prostaglandin Production and Extracellular Calcium (1979) (2)
- Nutrition and thrombogenic factors. (1999) (2)
- A role for steroid hormones in the variability of blood pressure determination. (1986) (2)
- C0421: Natural Anticoagulants Deficiency and the Risk of Venous Thromboembolism: A Meta-Analysis of Literature Studies (2014) (2)
- Convalescent plasma for administration of passive antibodies against viral agents (2020) (2)
- Upper tract urothelial cell carcinoma presenting as fever of unknown origin and acid-sterile pyuria (2012) (2)
- Hemostatic variables and ischemic cardiovascular disease: Do we need a concerted effort for more profitable future clinical investigations? (2004) (2)
- The Effect of Tiaprofenic Acid on Uric Acid Excretion in Man (2012) (2)
- Role of prostaglandins in captopril-induced natriuresis. (1985) (2)
- The International Prospective Glanzmann's Thrombasthenia Registry (GTR) Special Issues in Children (2012) (1)
- RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM (2007) (1)
- Commentary on: Borrini M, Garlaschelli L. A BPA Approach to the Shroud of Turin. J Forensic Sci https://doi.org/10.1111/1556-4029.13867. Epub 2018 July 10. (2019) (1)
- Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study (2011) (1)
- Venous thrombo-embolism (VTE) prevention of patients undergoing total hip and knee replacement: budget impact analysis of apixaban in Italy (2013) (1)
- Platelet effects of ω3 fatty acid ethyl esters (1994) (1)
- Nutrition and Cardiovascular Disease: ω-3 PUFA (2011) (1)
- Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions. (2009) (1)
- 117. Hirudin does not affect the abnormally high thromboxane biosynthesis in homozygous homocystinuria (1996) (1)
- Pharmacological treatment and prevention of chronic venous ulcers: a review. (2015) (1)
- Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue (2018) (1)
- [Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty]. (2006) (1)
- Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders. (2014) (1)
- FIBRINOGEN AND FACTOR VII IN THE CARDIOVASCULAR RISK FACTOR PROFILE (1999) (1)
- Developing relationships. Intracerebral bleeding, cardiovascular protection and haemostatic variables in moderate alcohol consumers (1992) (1)
- Recurrent Pulmonary Embolism and Pulmonary Hypertension in a Patient with β-Thalassemia Intermedia (2018) (1)
- Relation between PAI-1 Gene Locus Polymorphism and Family History of Coronary Artery Disease (1998) (1)
- The “antiphospholipid triangle” in an asymptomatic patient: a case report (2010) (1)
- Studies of Isoprostane Biosynthesis in Man (1996) (1)
- Venous thromboembolism: which patients are truly at risk? (2005) (1)
- SALICYLATES AND SURVIVAL OF HEART ALLOGRAFTS IN RATS (1979) (1)
- Erratum: Pathogen safety of long-term treatments for bleeding disorders: (Un)predictable risks and evolving threats (Seminars in Thrombosis and Hemostasis (2013) 39 (973)) (2013) (1)
- Progress, and prospects in the therapeutic armamentarium of persons with congenital hemophilia. Defining the place for liver-directed gene therapy. (2022) (1)
- The Arrival of Gene Therapy for Patients with Hemophilia A (2022) (1)
- Platelet receptors - Some methodological approaches (1981) (1)
- Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study (2019) (1)
- Platelet fibrinogen binding and vascular thrombosis (1988) (1)
- Periprocedural management of antithrombotic therapy and open issues in cancer patients. (2015) (1)
- 109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of ischemic stroke (1996) (1)
- Tromboembolismo Venoso Nei Pazienti Oncologici Linee Guida di Profilassi e Terapia E Aree di Incertezza (2006) (1)
- Platelet effects of omega 3 fatty acid ethyl esters. (1994) (1)
- Human genome, environment and medical practice (2013) (1)
- Thromboxane- and ADP-independent aggregation and exposure of fibrinogen receptors on platelets from patients with familial hypercholesterolemia. (1985) (1)
- Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques (1992) (0)
- Platelet Aggregation and Chronic Bronchopathies (1990) (0)
- [EPA and DHA ethyl esters: potential mechanisms of antischemic action]. (1999) (0)
- The Metabolic SYNDROME and the RISK of Venous Thrombosis: RESULTS of AN Individual LEVEL Patient Meta-ANALYSIS (2010) (0)
- 82. Determinants of plasma plasminogen activator inhibitor-1 antigen in subjects attending a metabolic ward (1996) (0)
- Membrane receptors for fibrinogen and factor VIII and abnormalities of platelet function. A review. (1985) (0)
- Effect of acetylsalicylate on surgical bleeding, postoperative mortality and allograft survival in rats undergoing heart transplantation (1979) (0)
- Persistent platelet accumulation of eicosapentaenoic acid and docosahexaenoic acid following withdrawal of a short-course supplementation of N-3 fatty acids ethyl esters. Association with impairment of the aggregation (1995) (0)
- Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) (2022) (0)
- XVI Convegno Triennale sui Problemi Clinici e Sociali dell'Emofilia e delle Malattie Emorragiche Congenite, Napoli, 9-12 Novembre 2017. (2017) (0)
- Hemorheological and hemostatic variables in coronary artery bypass surgery. Association with brain damage (1992) (0)
- We-W35:2 Inherited and acquired risk factors for juvenile myocardial infarction in an European cohort (2006) (0)
- THE PLATELET ANTIAGGREGATORY EFFECT OF ILOPROST IS ENHANCED BY ASPIRIN:IN VITRO AND EX VIVO STUDIES IN HUMAN SUBJECTS. (1987) (0)
- Prevalence of haemostatic abnormalities in women with 3 or more implantation failures afterin vitrofertilization (2003) (0)
- A survey on the views and attitudes of Italian physicians regarding the prophylaxis and treatment of venous thromboembolism (2020) (0)
- PRO95 FROM DRUG ACCESS TO VALUE BASED HEALTHCARE: INTEGRATED CARE PATHWAYS FOR HEMOPHILIA IN ITALY (2019) (0)
- Melvin Joel Silver (2003) (0)
- GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
- XVII Convegno Triennale sui Problemi Clinici e Sociali dell'Emofilia e delle Malattie Emorragiche Congenite, Milano, 8 - 11 ottobre 2020. (2020) (0)
- Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study (2023) (0)
- Corrigendum (2005) (0)
- Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER (2011) (0)
- FUNCTIONAL ANTITHROMBIN LEVELS AND RISK OF A FIRST EPISODE OF VENOUS THROMBOEMBOLISM (VTE). A CROSS-SECTIONAL STUDY (2011) (0)
- Low insulin-like growth factor (IGF) I, IGF binding protein-3 and acid labile subunit (ALS) levels in young ischemic stroke: a prospective case-control study (2008) (0)
- Influence of ACE-gene polymorphism on cardiovascular hypertrophy (1997) (0)
- Title Page / Table of Contents / Preface (2003) (0)
- Pathogen Safety of Long-Term Treatments for Bleeding Disorders: (Un)Predictable Risks and Evolving Threats (2013) (0)
- Long-Lasting Inhibition of Platelet Aggregation following a Relatively Short-Course Administration of N-3 Fatty Acid Ethyl Esters (1995) (0)
- [New oral anticoagulants: recommendations, precautions and perspectives for use]. (2012) (0)
- MYELOPROLIFERATIVE DISEASE CHARACTERIZED BY THROMBOSIS, BLEEDING AND PLATELET DYSFUNCTION IN MICE INJECTED WITH THE POLYOMA MURINE LEUKEMIA VIRUS (PyMLV) (1987) (0)
- The effect of LDL-apheresis on some hemostatic parameters in homozygous familial hypercholesterolemia (1990) (0)
- Effects of Enalapril on Water and Salt Balance and Renal Hemodynamics (1987) (0)
- Severe pancytopenia and intrahepatic cholestasis in a patient with a history of Hodgkin's disease. Responsiveness to high-dose pulse steroid therapy and diagnosis of a late relapse. (2001) (0)
- Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders. (2015) (0)
- Denaturing Hplc Procedure for Factor Ix (0)
- C-reactive protein and family history of myocardial infarction (1999) (0)
- Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study (2018) (0)
- Contents Vol. 32, 2002 (2002) (0)
- Management of Antithrombotic Drugs in Patients with Isolated Traumatic Brain Injury: An Intersociety Consensus Document. (2023) (0)
- C-reactive protein and family history of myocardial infarction (1999) (0)
- Tu-P7:104 Preclinical cardiovascular abnormalities and thrombotic risk in patients with primary glomerulonephritis with mild or no impairment of renal function (2006) (0)
- Melvin Joel Silver (2003) (0)
- UNIVERSITY OF NAPLES "FEDERICO II" Doctorate School in Advanced Medical and Surgical Therapies XXIX Cycle (2017) (0)
- 2.P.221 Genetic susceptibility to coronary artery disease: Involvement of a polymorphism of the PAI-1 gene locus (1997) (0)
- 1.P.305 PAI-1 gene polymorphism in patients with premature coronary heart disease (1997) (0)
- Contents Vol. 47, 2001 (2001) (0)
- P-56 Pituitary function in young ischemic stroke patient: preliminary data (2008) (0)
- Prophylaxis of venous thromboembolism in elderly patients with multi-morbidity: the REPOSI data (2014) (0)
- [Absence of an association of the D allele of the ACE gene with arterial pressure in mild-moderate essential arterial hypertension]. (1996) (0)
- Urinary excretion of iPF2α-III predicts the risk of future thrombotic events. A 10-year follow-up (2011) (0)
- Analisi costo-efficacia di caplacizumab nel nuovo standard of care della porpora trombotica trombocitopenica immune in Italia (2021) (0)
- PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS (2007) (0)
- Prophylaxis of venous thromboembolism in elderly patients with multi-morbidity: the REPOSI data (2015) (0)
- Nutrition and Cardiovascular Disease: Homocysteine (2011) (0)
- Contents, Vol. 17, (Suppl. 1), 1978 (1978) (0)
- Increased prostacyclin activity in vascular tissues from rats on prolonged treatment with oral contraceptives (OC) (1979) (0)
- Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques (1996) (0)
- Plasma lipoprotein(a) level is not elevated in patients with a history of ischemic stroke (1995) (0)
- Aspirin as an antithrombotic agent. (1989) (0)
- Aggregation of human peripheral blood mononuclear cells by calcium ionophore A23187. Comparison with the aggregation of platelets and defective response in Glanzmann's thrombasthenia (1988) (0)
- Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study (2022) (0)
- PROSPECTIVE STUDY OF THE IMMUNOLOGICAL MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA A PATIENTS WITH INHIBITORS (2017) (0)
- Transient Global Amnesia in a Young Woman on Prolonged Treatment with Oral Contraceptive Drugs (1996) (0)
- Advances in Basic , Laboratory and Clinical Aspects of Thromboembolic Diseases * PLATELET AND MONOCYTE VARIABLES IN HOMOCYSTINURIA DUE TO CYSTATHIONINE-b-SYNTHASE DEFICIENCY (2005) (0)
- Subject Index Vol. 47, 2001 (2001) (0)
- Gene-Environment Interaction in the Molecular Regulation of Plasma Coagulation Proteins (2011) (0)
- PRO34 Cost-Effectiveness Analysis of Caplacizumab in Combination with Plasmapheresis and Immunosuppression in Patients with Acquired Thrombotic Thrombocytopenia Purpura (ATTP) in Italy (2020) (0)
- Morphological and functional abnormalities in platelets exposedin vitro to ioglicinic acid, a new ionic contrast medium (1987) (0)
- [Impairment of diuresis in surgical intervention. Role of urinary prostaglandins]. (1990) (0)
- The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status. (2023) (0)
- ABNORMAL FIBRINOGEN (FIBRINOGEN NAPLES) CHARACTERIZED BY DETECTIVE INTERACTION WITH THROMBIN AND PLASMIN IN TWO YOUNG SIBLINGS WITH ARTERIAL THROMBOSIS (1987) (0)
- 118. Infusion of hirudin does not correct the abnormally high thromboxane A2 biosynthesis in homozygous homocystinuria (1996) (0)
- Erratum: Reduced in vivo oxidative stress following 5- methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype (British Journal of Haematology (2005) 131 (100-106)) (2005) (0)
- 2.P.366 High prevalence of homozigosity for the 677C → T mutation of the 5;10-methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in patients with early-onset thrombotic events (1997) (0)
- Enzymatic and Genetic Analysis of Cu/Zn Superoxide Dismutase in Non-Familial Alzheimer’s Disease (1995) (0)
- New opportunities in Haemophilia treatment: Efmoroctocog Alfa for patients with Haemophilia A (2022) (0)
- Hypersensitivity To Exogenous Arachidonic Acid (Aa) And Redistribution Of Fatty Acids In Platelets From Women On The Pill (1981) (0)
- [ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism]. (2016) (0)
- Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre. (2022) (0)
- PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY (2007) (0)
- Commentary on: Borrini M, Garlaschelli L. A BPA Approach to the Shroud of Turin. J Forensic Sci 2019;64(1):137–43. (2019) (0)
- Oxidative stress and platelet eicosanoid synthesis in disease (2009) (0)
- [Laboratory investigations in the diagnosis of pathologies of hemostasis]. (1986) (0)
- OP13 The hydrogen sulfide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia (2013) (0)
- A survey on the views and attitudes of Italian physicians with regards to venous thromboembolism prophylaxis and treatment. (2019) (0)
- Dietary Advice for the Prevention of Arterial Thrombosis (1993) (0)
- 108. the C677T mutation of the 5, 10-methylenetetrahydropholate reductase gene (MTHFR) and moderate hyperhomocysteinemia in young thrombophilic patients (1996) (0)
- Fibrinolytic, Platelet and Monocyte Variables in Homozygous Familial Hypercholesterolemia. The Effect of a Regular Plasma Cholesterol Removal by LDL-apheresis (1993) (0)
- Genetic Polymorphisms and Arterial Thrombosis (1998) (0)
- [Prevention of venous thromboembolism: how important is it in non-surgical disease?]. (2001) (0)
- 81. A variant of the angiotensin-converting enzyme gene in patients with a history of ischemic stroke (1996) (0)
- Persistent total plasma homocysteine reduction and folate accumulation following one month course of methyltetrahydrofolate (Prefolic (R)) administration in patients with moderate hyperhomocysteinemia, thrombosis, and the thermolabile MTHFR variant (1998) (0)
- Thrombotic Risk During r-EPO Therapy in Hemodialyzed Patients. A New Hypothesys (1991) (0)
- Abnormally high fibrinolytic variables in survivors of ischemic stroke (1994) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Giovanni Di Minno?
Giovanni Di Minno is affiliated with the following schools:
